DoseMe

Name

DoseMe

Legal name

DoseMe Pty Ltd

Website

https://doseme-rx.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Pharmacology & Pharmacometrics (Modeling & Simulation) (HLAIALAG)

akta.pro secondary industries

Medication Analytics, Outcomes & Cost Optimization (HLACAKAL), Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH), Medication Therapy Management (MTM) & Clinical Pharmacy Services (HLAFALAH)

Keywords

• Bayesian dosing software
• Precision medication dosing
• Therapeutic drug monitoring
• Clinical decision support
• Pharmacokinetic dosing platform

Headquarters

HQ city

Brisbane

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Software Licensing (DoseMeRx): Licensed software product sold to healthcare organizations. Pricing based on number of sites in hospital system and type of access required (web-based standalone or EHR-integrated). Includes custom integration by DoseMeRx engineering team, virtual or on-site training, 24/7 customer support, and access to clinical advisory board resources.
2. DoseMe Analytics: Analytics dashboard product providing real-time clinical data visualization. Sold as part of integrated license options or standalone subscription.
3. EHR Integration Services: Custom integration engineering services for Epic, Cerner, and pharmacy surveillance software implementations. Included as part of integrated license options.

Pricing tiers

Go-to-market motion4 records

Distribution channels8 records

Marketing channels7 records

Core offering

DoseMe sells DoseMeRx, a Bayesian dosing software platform that uses clinically-validated pharmacokinetic/pharmacodynamic models combined with individual patient characteristics (age, height, weight, sex, genotype) and drug concentration data to calculate patient-specific, individualized drug doses in seconds. The platform covers drugs with narrow therapeutic windows across infectious diseases, oncology, transplant, cardiovascular, biologics, and pediatrics, and is offered as a web-based solution or embedded within Epic and Cerner EHRs. DoseMe Analytics, an add-on module, provides real-time dashboards for dosing performance, protocol compliance, and outcomes tracking.

Product overview

DoseMe offers DoseMeRx as its core Bayesian dosing platform, supplemented by DoseMe Analytics as an embedded analytics module. DoseMeRx provides model-informed precision dosing (MIPD) software that calculates patient-specific drug doses using clinically-validated pharmacokinetic/pharmacodynamic models combined with individual patient data. The platform is available via web-based access or through EHR integrations with Epic and Cerner. DoseMe Analytics provides real-time dashboards and reporting capabilities embedded within the core platform.

Differentiator

Problem solved

Functional benefit

Brands

• DoseMeRx: The primary Bayesian dosing software platform providing precision dosing calculations for clinicians
• DoseMe Analytics

Products and services

• DoseMeRx Bayesian dosing software platform that calculates patient-specific drug doses using clinically-validated pharmacokinetic/pharmacodynamic models combined with patient characteristics, drug concentrations, and genotype. Sold to hospitals and health systems for precision dosing of narrow therapeutic index drugs across infectious diseases, oncology, transplant, cardiovascular, biologics, and pediatrics. Available as a web-based solution or embedded within Epic and Cerner EHRs.
• DoseMe Analytics Analytics dashboard module that provides real-time visualization of dosing data, AUC vs trough outcomes, patient risk, time to therapeutic targets, daily dosages, drug model usage, and protocol compliance. Sold as a standalone subscription or bundled with DoseMeRx to clinical pharmacy teams monitoring prescribing practices across health systems.

Quantifiable outcome

• 70% decrease in rate of kidney injury reported by A.C. Camargo Cancer Center
• +4 more outcomes

Named customers21 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability2 records

Feature9 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• FirstlinecoreStrategic or Co-development Partner · 3 November 2025DoseMe acquired Firstline, a leading mobile-first clinical decision support platform for infectious disease treatment guidance. Firstline enables clinicians to rapidly access local, evidence-based treatment guidance, susceptibility patterns, and antimicrobial stewardship resources. The combination creates a unified platform from therapy selection through personalized dosing for the global fight against infectious disease.
• Wolters KluwerminorGTM or Marketing PartnerJoint webinars on vancomycin Bayesian dosing co-presented with Wolters Kluwer. Collaboration for educational content around precision dosing and 2020 vancomycin guidelines.
• CernercoreTechnology or IntegrationIntegration partnership with Cerner Millennium EHR. DoseMeRx is embedded within the Cerner platform for seamless in-workflow dosing decisions. Automatic patient data loading eliminates manual entry. Companies co-presented at Cerner Health Conference 2017.
• EpiccoreTechnology or IntegrationIntegration partnership with Epic EHR through Epic App Orchard. DoseMeRx has increased FHIR power in Epic's App Orchard for enhanced interoperability. Embedded integration provides seamless access to dosing recommendations within Epic workflows.
• Dot.libminorOEM/ Whitelabel/ Licensing PartnerExpanded licensing agreement with Dot.lib for distribution of DoseMeRx content and platform access.
• Keegan Mason & AssociatesminorChannel Partner/ Reseller/ DistributorCollaboration to advance clinical outcomes and antimicrobial stewardship specifically targeting rural and community hospitals in the United States.
• DaiKnowminorChannel Partner/ Reseller/ DistributorPartnership to advance model-informed precision dosing in India market. Expanding DoseMe's global footprint into South Asia.
• IscientiaminorChannel Partner/ Reseller/ DistributorIscientia added DoseMeRx to expand portfolio and revolutionize healthcare practices.
• Primum PharmaminorChannel Partner/ Reseller/ DistributorExpanded reseller agreement with Primum Pharma into the MENA (Middle East and North Africa) market. Also covers Turkey distribution.
• Albertina icome PrahaminorChannel Partner/ Reseller/ DistributorPartnership with Albertina icome Praha for distribution and reseller services in Czech Republic and Slovakia as demand for precision dosing increases in the region.
• Bainbridge Health PartnersminorChannel Partner/ Reseller/ DistributorPartnership to expand medication management capabilities to health systems through DoseMe integration.
• HealixminorChannel Partner/ Reseller/ DistributorStrategic partnership with Healix for precision dosing services.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Insight Rx: Insight Rx is a direct competitor offering a Bayesian dosing platform for precision dosing of vancomycin, aminoglycosides, and other therapeutic agents in hospital settings. It targets similar clinical pharmacist customers and overlaps materially on drug model coverage and EHR integration strategy.
• Sanford Guide: Sanford Guide is a leading antimicrobial stewardship content reference integrated with DoseMeRx but also sold independently to clinicians. It is comparable because it provides treatment-guidance content that competes directly with DoseMe's recent Firstline acquisition and overlaps on infectious-disease decision support.
• PrecisePK: PrecisePK is a direct peer offering Bayesian dosing software for clinical pharmacokinetic monitoring in hospitals, with comparable use cases in vancomycin AUC dosing and aminoglycoside TDM. It is a frequently cited alternative to DoseMeRx in clinical pharmacy literature and procurement decisions.

Broad incumbents

• Elsevier (Clinical Pharmacology / ClinicalPath): Elsevier's Clinical Pharmacology and ClinicalPath products provide drug reference and clinical decision support content used by hospitals alongside dosing workflows. Comparable as a broader incumbent whose drug content and CDS suite overlaps thematically with DoseMe's clinical evidence and dosing recommendations.
• First Databank (FDB): First Databank, an Hearst Health company, is a broad incumbent in drug knowledge and clinical decision support, providing drug reference data and screening tools embedded in EHR workflows. It is comparable as an adjacent clinical-content provider whose drug data and CDS modules could overlap with DoseMe's dosing recommendations over time.
• Tabula Rasa HealthCare (Quantal Health): Tabula Rasa HealthCare (now Quantal Health) is a broader medication management and pharmacy services incumbent that has historically offered precision dosing capabilities. It operates at a larger scale across PACE and senior care populations, partially overlapping with DoseMe's home infusion and elderly patient use cases.
• Wolters Kluwer (Sentri7 / Pharmacy OneSource): Wolters Kluwer operates Sentri7 and Pharmacy OneSource, which are integrated with DoseMeRx but also offer broader pharmacy surveillance and clinical decision support. Comparable as an incumbent with overlapping antimicrobial stewardship and pharmacy content capabilities across the same hospital customer base.
• McKesson (Pharmacy Solutions / Macro Helix): McKesson offers pharmacy and medication management solutions at scale to hospital systems, including antimicrobial stewardship programs. Comparable as a broad incumbent whose commercial reach and prior stewardship program launches (where DoseMe's CEO previously worked) place it in adjacent competition for hospital pharmacy IT budgets.

Regional players

• PharMerica / BrightSpring Health Services: BrightSpring Health Services and its pharmacy subsidiaries (including PharMerica) serve long-term care, home infusion, and specialty pharmacy populations with medication management services. Comparable as a regional US-based player whose clinical pharmacy and home infusion customer base overlaps with DoseMe's home infusion and PACE use cases.

Emerging players

• VigiLanz: VigiLanz is a pharmacy surveillance platform that integrates with DoseMeRx and offers adjacent antimicrobial stewardship and clinical surveillance capabilities. It is comparable as a peer/partner that competes for hospital pharmacy IT wallet share while enabling DoseMe distribution through its installed base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/dosemeapp
• Facebookfacebook.com/dosemeapp
• LinkedInlinkedin.com/company/doseme-pty-ltd

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DoseMe